Sebastian Hunte

Oshen make and deploy constellations of rugged ocean robots for wide area, long duration ocean monitoring.

Building Infra for Next-Gen Reasoning-based RAG

Were developing a category defining neurotech platform that uses next-generation ultrasound technology to non-invasively treat and interface with the brain. Our approach uses precisely focused sound waves to safely modulate specific brain circuits, establishing a new paradigm for non-invasive brain-computer interaction and therapeutic intervention. Transcranial ultrasound technology shows remarkable promise, not only for treating neurological and psychiatric conditions but also as a foundation for next-generation neuromodulation applications. Our founding team combines expertise in ultrasound engineering and clinical neuroscience from world-leading institutions in medical technology and brain science. Were combining cutting-edge engineering with deep neuroscientific understanding to build what could become the gold standard for non-invasive neuromodulation, potentially transforming the lives of millions affected by brain disorders while opening new frontiers in brain-computer interaction.

This is a catchall company for the doers, the thinkers, and the innovators.

A new company that will revolutionise the performance of AI systems and speed up data centres, whilst dramatically reducing energy consumption for a sustainable future.

We make batteries charge faster, much faster. Our technology has been demonstrated on commercial Li-ion cells to accelerate charging by up to 67%.

Oshen make and deploy constellations of rugged ocean robots for wide area, long duration ocean monitoring.

Building Infra for Next-Gen Reasoning-based RAG

AlbionVC backs Europe’s visionary founders solving the world’s hardest problems. We bring capital, know-how, and a shared ambition to win. With £1 billion in venture funds and conviction led investing across frontier technologies, our track record spans 100+ exits and early support for global champions such as Booking.com, Quantexa, Oviva, Elliptic and tem. From the first concept to global scale, we back founders bold enough to own the future.

Were developing a category defining neurotech platform that uses next-generation ultrasound technology to non-invasively treat and interface with the brain. Our approach uses precisely focused sound waves to safely modulate specific brain circuits, establishing a new paradigm for non-invasive brain-computer interaction and therapeutic intervention. Transcranial ultrasound technology shows remarkable promise, not only for treating neurological and psychiatric conditions but also as a foundation for next-generation neuromodulation applications. Our founding team combines expertise in ultrasound engineering and clinical neuroscience from world-leading institutions in medical technology and brain science. Were combining cutting-edge engineering with deep neuroscientific understanding to build what could become the gold standard for non-invasive neuromodulation, potentially transforming the lives of millions affected by brain disorders while opening new frontiers in brain-computer interaction.

This is a catchall company for the doers, the thinkers, and the innovators.